ATE486607T1 - Viskosupplementation mit algen-polysacchariden bei der behandlung von arthritis - Google Patents

Viskosupplementation mit algen-polysacchariden bei der behandlung von arthritis

Info

Publication number
ATE486607T1
ATE486607T1 AT06821630T AT06821630T ATE486607T1 AT E486607 T1 ATE486607 T1 AT E486607T1 AT 06821630 T AT06821630 T AT 06821630T AT 06821630 T AT06821630 T AT 06821630T AT E486607 T1 ATE486607 T1 AT E486607T1
Authority
AT
Austria
Prior art keywords
arthritis
joint
viscosupplementation
treatment
polysaccharides
Prior art date
Application number
AT06821630T
Other languages
English (en)
Inventor
Shosh Arad
Dan Atar
Original Assignee
Univ Ben Gurion
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Ben Gurion filed Critical Univ Ben Gurion
Application granted granted Critical
Publication of ATE486607T1 publication Critical patent/ATE486607T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Lubricants (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT06821630T 2005-12-08 2006-12-07 Viskosupplementation mit algen-polysacchariden bei der behandlung von arthritis ATE486607T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL172477A IL172477A (en) 2005-12-08 2005-12-08 Addition of viscosity by algae polysaccharides to treat arthritis
PCT/IL2006/001412 WO2007066340A1 (en) 2005-12-08 2006-12-07 Viscosupplementation with algal polysaccharides in the treatment of arthritis

Publications (1)

Publication Number Publication Date
ATE486607T1 true ATE486607T1 (de) 2010-11-15

Family

ID=37745922

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06821630T ATE486607T1 (de) 2005-12-08 2006-12-07 Viskosupplementation mit algen-polysacchariden bei der behandlung von arthritis

Country Status (7)

Country Link
US (1) US9119870B2 (de)
EP (1) EP1957088B1 (de)
AT (1) ATE486607T1 (de)
DE (1) DE602006018058D1 (de)
ES (1) ES2361024T3 (de)
IL (1) IL172477A (de)
WO (1) WO2007066340A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3398606T3 (pl) * 2006-01-19 2022-02-07 Algenist Holdings, Inc, Kompozycje otrzymane z mikroalg poprawiające zdrowie i wygląd skóry
US8277849B2 (en) 2006-01-19 2012-10-02 Solazyme, Inc. Microalgae-derived compositions for improving the health and appearance of skin
US8298548B2 (en) 2007-07-18 2012-10-30 Solazyme, Inc. Compositions for improving the health and appearance of skin
US8927522B2 (en) 2008-10-14 2015-01-06 Solazyme, Inc. Microalgal polysaccharide compositions
WO2010054322A1 (en) 2008-11-07 2010-05-14 Solazyme, Inc. Cosmetic compositions comprising microalgal components
ES2718275T3 (es) * 2009-03-27 2019-06-28 Algenist Holdings Inc Composiciones de polisacáridos de microalgas
US9597280B2 (en) 2013-05-15 2017-03-21 Terravia Holdings, Inc. Cosmetic compositions comprising microalgal oil
EP3068316B1 (de) 2013-11-13 2019-08-07 Thixos LLC Vorrichtungen und kits für die behandlung von facettengelenken
KR101833667B1 (ko) * 2017-02-14 2018-03-12 주식회사씨에스텍 청각 추출물을 유효성분으로 포함하는 관절연골 보호 또는 치료용 약학적 조성물

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4281061A (en) * 1979-07-27 1981-07-28 Syva Company Double antibody for enhanced sensitivity in immunoassay
US5910512A (en) * 1994-04-18 1999-06-08 Healthline Laboratories, Inc. Topical analgesic using water soluble capsaicin
US5612321A (en) * 1995-06-22 1997-03-18 Hercules Incorporated Antioxidant grafted polysaccharides
CA2249103A1 (en) 1997-10-27 1999-04-27 Samir S. Badour Novel hyaluronic acid produced from algae
JP3573941B2 (ja) * 1998-02-13 2004-10-06 マイクロアルジェコーポレーション株式会社 ヒアルロニダーゼ阻害活性を有する組成物及び該組成物を含有する化粧料
FR2785909A1 (fr) * 1998-11-16 2000-05-19 Aquamer Extrait de micro-algues contenant des substances antiradicalaires et des polysaccharides sulfates et composition l'incorporant
SE0001631D0 (sv) * 2000-05-04 2000-05-04 Sahltech Ab New use
US20050196410A1 (en) * 2004-03-05 2005-09-08 Daniels Bruce A. Seaweed extract composition for treatment of inflammation

Also Published As

Publication number Publication date
IL172477A0 (en) 2006-04-10
US20090017058A1 (en) 2009-01-15
IL172477A (en) 2012-06-28
DE602006018058D1 (de) 2010-12-16
EP1957088A1 (de) 2008-08-20
WO2007066340A1 (en) 2007-06-14
EP1957088B1 (de) 2010-11-03
US9119870B2 (en) 2015-09-01
ES2361024T3 (es) 2011-06-13

Similar Documents

Publication Publication Date Title
MX2021005887A (es) Compuestos de 2-formil-3-hidroxifeniloximetilo capaces de modular hemoglobina.
MX2017005784A (es) Dextranos gelificantes enzimaticamente polimerizados.
WO2018154380A8 (en) Compositions and methods for treatment of proprotein convertase subtilisin/kexin type 9 (pcsk9)-related disorders
AU2017232084B2 (en) Methods of treating or preventing cholesterol related disorders
PH12020550964A1 (en) Heavy chain antibodies binding to cd22
MY197720A (en) Bicyclic heterocycles as fgfr inhibitors
CR20220656A (es) Unión de anticuerpos multiespecíficos a bcma
JO2576B1 (en) Antibodies
NO20091209L (no) Fremgangsmate for a kontrollere rate av syredannende forbindelse ved syrebehandling
MX2017016602A (es) Tratamientos de yacimientos.
PL381801A1 (pl) Pochodne mocznika, kompozycje zawierające pochodne mocznika oraz zastosowanie pochodnych mocznika do wytwarzania leku do leczenia skurczowej niewydolności serca
MX2021015500A (es) Pirazolo-pirazinas sustituidas y su uso como moduladores del receptor glun2b.
ECSP067014A (es) Modulación de producción de inmunoglobulina y trastornos atópicos
MX2021015503A (es) Pirazolo piridinas heteroaromáticas sustituidas y su uso como moduladores del receptor glun2b.
WO2021146320A8 (en) Antibody molecules to c5ar1 and uses thereof
CR20210580A (es) Amidas depirazol-piridina sustituidos y su uso como moduladores del receptor glun2b
ATE486607T1 (de) Viskosupplementation mit algen-polysacchariden bei der behandlung von arthritis
WO2022218941A3 (en) Compositions and methods for inhibiting ketohexokinase (khk)
WO2017139697A8 (en) Bacteria engineered to treat diseases associated with hyperammonemia
MX2023010711A (es) Fenalquilaminas y métodos de preparación y uso de las mismas.
WO2021091885A3 (en) Siglec-9 ecd fusion molecules and methods of use thereof
MX2023005591A (es) Metodos de tratamiento de enfermedades y trastornos.
MX2025002903A (es) Compuestos para la degradación dirigida de proteínas
WO2018175749A3 (en) LRP1 BINDING AGENTS AND USES THEREOF
MX2019001691A (es) Composiciones que comprenden biopolímeros y métodos para su elaboración.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties